Article
Model-Driven Hybrid AI Framework for End-to-End Autonomous Decision-Making in Drug Development
2026-02-06
Abstract excerpt
Decision-making in drug development spans heterogeneous stages from molecular design to clinical optimization, yet computer-aided workflows across stages remain fragmented, limiting traceability from evidence-derived clinical questions to simulation scenarios and decision endpoints. We present a model-driven hybrid AI framework for end-to-end decision support that treats PICO (Participants, Intervention, Compariso...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5f79a8d1-42cb-57ba-a4cc-513bee9784c6
- DOI
- 10.64898/2026.02.03.703154
